DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Pyrogen Testing Market - Global Forecasts to 2021" report to their offering.
The global pyrogen testing market is projected to reach USD 1086.3 million by 2021 from USD 610.2 million in 2016, at a CAGR of 12.2% from 2016 to 2020.
The major drivers for the market include increase in pharmaceutical and biological industries and increasing number of new drug launches. Over the years, the number of drug approvals in North American countries has increased from 2006 to 2015. In 2015, the FDA's Center for Drug Evaluation and Research (CDER) approved 45 novel drugs, approved as new molecular entities (NMEs) under New Drug Applications (NDAs) or as new therapeutic biologics under Biologics License Applications (BLAs) as compared to 22 novel drugs approved in 2006. The increasing number of drug approvals will boost the pyrogen testing market.
According to OECD estimates, in 2011, the total number of biotechnology companies in the U.S. was 7,970, followed by Spain (3,025 biotechnology companies), and France (1,481 biotechnology companies).
Owing to the rise in the number of biotechnology companies, biopharmaceutical production has increased globally. Pyrogen testing is carried out at all levels of pharmaceutical and biopharmaceutical manufacturing process to minimize the risk of product contamination. Growth in pharmaceutical and biotechnology industries will drive the growth of the pyrogen testing market.
- Associates of Cape Cod, Inc.
- Charles River Laboratories, Inc.
- Ellab A/S
- Hyglos GmbH
- Lonza Group
- Merck Kgaa
- Thermo Fisher Scientific, Inc.
- WUXI Pharmatech (Cayman) Inc.
Wako Chemicals Usa, Inc.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Pyrogen Testing Market, By Product
8 Pyrogen Testing Market, By Application
9 Pyrogen Testing Market, By Test Type
10 Pyrogen Testing Market, By Region
11 Competitive Landscape
12 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/4lspct/pyrogen_testing
Related Topics: Infectious Disease Testing
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716